Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty

NCT: NCT04968405 · COMPLETED

NCT IDNCT04968405
StatusCOMPLETED
Start Date2022-07-22
Completion2026-02-01

Brief Summary

Evaluation of the performance and safety of the Catalyst CSR Shoulder System with clinical and radiographic results at multiple time points through 24 months postoperatively This study will be a prospective multi-center study conducted in the United States.

Frequently Asked Questions

What is Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty?

Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty is a clinical trial registered under NCT04968405. Current status: COMPLETED.

What is the status of NCT04968405?

The current status of NCT04968405 (Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty) is: COMPLETED.

When did Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty start?

Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty started on 2022-07-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.